KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Markers in umbilical cord blood in early-onset fetal growth restricted fetuses.

Alba González, Anna Peguero, Eva Meler, Águeda Barberá, Maria Dolores Gomez-Roig, Daniel Oros, Jon Schoorlemmer, Ana Medel, Alberto Montolio, Maria Dolors Tàssies, Francesc Figueras, Edurne Mazarico

Placenta 182 28-36

PMID42215002
PMCID-
DOI10.1016/j.placenta.2026.05.015
发表日期2026-05-29
摘要

摘要

INTRODUCTION: Early-onset fetal growth restriction (FGR) is a severe form of placental insufficiency associated with high perinatal morbidity. Its pathophysiology involves angiogenic imbalance, endothelial dysfunction, and inflammation. Low-molecular-weight heparin (LMWH) has anti-inflammatory and pro-angiogenic properties, but its effects on fetal molecular pathways remain unclear. METHODS: This phase III, multicenter, triple-blind randomized trial was conducted in two Spanish university hospitals between January 1, 2019 and January 31, 2023. Singleton pregnancies with early-onset FGR (20+0-31 + 6 weeks) defined by adapted Delphi criteria were randomized to receive bemiparin (3500 IU/day) or placebo from diagnosis until delivery. Umbilical cord blood biomarkers were measured at birth and compared with gestational age-matched preterm controls (±2 weeks). RESULTS: Seventy-seven neonates (30 FGR, 47 controls) were analyzed. FGR fetuses showed higher leptin receptor, endoglin (CD105), and E-selectin, and lower VEGF-A compared with controls (p ≤ 0.05). No differences were observed between LMWH and placebo within the FGR group. A significant linear trend (control → LMWH → placebo) was found for all biomarkers except IL-6. DISCUSSION: Early-onset FGR is associated with a distinct fetal profile characterized by endothelial activation and angiogenic imbalance, independent of prematurity. Prophylactic LMWH initiated at diagnosis did not modify these pathways, suggesting that fetal alterations are already established and not responsive to treatment at this stage. These findings support the need for earlier or alternative therapeutic strategies targeting placental dysfunction.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。